Correlation Between Neuropace and Glaukos Corp
Can any of the company-specific risk be diversified away by investing in both Neuropace and Glaukos Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neuropace and Glaukos Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neuropace and Glaukos Corp, you can compare the effects of market volatilities on Neuropace and Glaukos Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neuropace with a short position of Glaukos Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neuropace and Glaukos Corp.
Diversification Opportunities for Neuropace and Glaukos Corp
0.77 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Neuropace and Glaukos is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding Neuropace and Glaukos Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Glaukos Corp and Neuropace is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neuropace are associated (or correlated) with Glaukos Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Glaukos Corp has no effect on the direction of Neuropace i.e., Neuropace and Glaukos Corp go up and down completely randomly.
Pair Corralation between Neuropace and Glaukos Corp
Given the investment horizon of 90 days Neuropace is expected to generate 3.65 times less return on investment than Glaukos Corp. In addition to that, Neuropace is 2.55 times more volatile than Glaukos Corp. It trades about 0.01 of its total potential returns per unit of risk. Glaukos Corp is currently generating about 0.11 per unit of volatility. If you would invest 9,430 in Glaukos Corp on November 3, 2024 and sell it today you would earn a total of 6,214 from holding Glaukos Corp or generate 65.9% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Neuropace vs. Glaukos Corp
Performance |
| Timeline |
| Neuropace |
| Glaukos Corp |
Neuropace and Glaukos Corp Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Neuropace and Glaukos Corp
The main advantage of trading using opposite Neuropace and Glaukos Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neuropace position performs unexpectedly, Glaukos Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Glaukos Corp will offset losses from the drop in Glaukos Corp's long position.| Neuropace vs. Electromed | Neuropace vs. Orthopediatrics Corp | Neuropace vs. SurModics | Neuropace vs. Paragon 28 |
| Glaukos Corp vs. Orthopediatrics Corp | Glaukos Corp vs. CONMED | Glaukos Corp vs. LivaNova PLC | Glaukos Corp vs. Paragon 28 |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Transaction History View history of all your transactions and understand their impact on performance |